NCT00824603

Impact of Continuing Medical Education (CME) Insulin Program

Impact of CME Program on Self-Reported Confidence and Use of Insulin in Persons With Type 2 Diabetes

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 294 (actual)
• Sponsor: HealthPartners Institute · Academic / Other
• Sex: All
• Age: 25 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.

Detailed description

We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program. Specifically, we will address the following questions: Question 1. Clinical guidelines. Is insulin initiated earlier (at a lower A1C)? Question 2. Decision-making. Does confidence in selecting a starting insulin regimen change? Does confidence in selecting a starting insulin dose change? Does confidence in adjusting insulin change? Does confidence in discussion nutrition guidelines change? Question 3. Application. Do more patients start using insulin? Who usually selects starting dose? How is starting dose selected? How often is insulin adjusted? Question 4. Resources. How available are protocols for insulin use? How available is adequate time to monitor insulin therapy? How available is staff to teach insulin injections? How available is staff to help adjust insulin?

Conditions

• Diabetes

Timeline

• Start date: 2006-06-01
• Primary completion: 2009-08-01
• Completion: 2009-08-01
• First posted: 2009-01-19
• Last updated: 2015-12-02

Locations

1 site across 1 country: United States